Y. Hanazawa et al., CHARACTERIZATION OF NICOTINAMIDE METHYLTRANSFERASE IN LIVERS OF MICE BEARING EHRLICH ASCITES TUMORS - PREFERENTIAL INCREASE OF ACTIVITY, Tumor biology, 15(1), 1994, pp. 7-16
There was a 2- to 7-fold increase in nicotinamide methyltransferase ac
tivity in the livers of mice and rats bearing seven different kinds of
tumors compared with the respective control normal livers, while acti
vity in the tumors themselves was hardly detectable. The activity in t
he liver started to increase markedly 3-7 days after i.p. transplantat
ion of Ehrlich ascites tumors into the mice, maintaining a plateau up
to death. Metabolic conversion of C-14-nicotinamide to C-14-N-1-methyl
nicotinamide was 3-fold higher in the slices of the ascites tumor host
liver than in the normal liver, but the conversion to other radioacti
ve metabolites was not significantly different. Nicetinamide methyltra
nsferase was finally purified 20,000-fold with a yield of 4% from the
cytosolic fraction of the ascites tumor host liver by means of five pu
rification steps. At every purification step, only one enzyme fraction
was detected. The enzyme finally isolated exhibited a single protein
band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, wit
h a molecular weight of 26,000. As for the compounds investigated, inc
luding the substrates for methyltransferases other than nicotinamide m
ethyltransferase, only quinoline could be the substrate for enzyme act
ivity. It is suggested that the increase in enzyme activity in the tum
or host liver probably derived from the endogenous enzyme preexisting
in the liver before tumor transplantation.